
Uppsala Reports editor
@UMCGlobalSafety
Photo: iStock
Drug Safety Matters dives into the fascinating field of pharmacogenomics and the implications it has for tailored treatments and safer prescribing practices.
Genetic variation is one of the reasons people differ in their response to medicines. Understanding that variation can inform more refined choices of drugs and doses – ultimately preventing undesired side effects. Join us as we discuss past, present and future of pharmacogenomics with Uppsala Monitoring Centre’s Qun-Ying Yue.
Subscribe by visiting the Drug Safety Matters website or listen in right here:
Read more
Pharmacogenomics group aims to refine patient safety options
The CARTA Early Career Pharmacovigilance Research Grant is putting African-led patient-centred pharmacovigilance on the map.
Research / 22 April 2022
With multiple medicine use on the rise, a UK study has set out to gather evidence for safer practices to get patients off the drugs they no longer need.
Research / 16 June 2021
Check in with UMC’s head of pharmacovigilance science to catch up with her team’s current research priorities.
Research / 09 April 2021